scholarly journals Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

2018 ◽  
Vol 27 (02) ◽  
pp. 081-091 ◽  
Author(s):  
Takao Ohki ◽  
Yuji Kanaoka ◽  
Koji Maeda

AbstractThe technologies and innovations applicable to endovascular treatment for complex aortic pathologies have progressed rapidly over the last two decades. Although the initial outcomes of an endovascular aortic repair have been excellent, as long-term data became available, complications including endoleaks, endograft migration, and endograft infection have become apparent and are of concern. Previously, the indication for endovascular therapy was restricted to descending thoracic aortic aneurysms and abdominal aortic aneurysms. However, its indication has expanded along with the improvement of techniques and devices, and currently, it has become possible to treat pararenal aortic aneurysms and Crawford type 4 thoracoabdominal aortic aneurysm (TAAA) using the off-the-shelf devices. Additionally, custom-made devices allow for the treatment of arch or more extensive TAAAs. Endovascular treatment is applied not only to aneurysms but also to acute/chronic dissections. However, long-term outcomes are still unclear. This article provides an overview of available devices and the results of endovascular treatment for various aortic pathologies.

1999 ◽  
Vol 82 (S 01) ◽  
pp. 171-175 ◽  
Author(s):  
D. Ebert ◽  
M. Langer ◽  
P. Uhrmeister

SummaryThe endovascular treatment of abdominal aortic aneurysms has generated a great deal of interest since the early 1990s, and many different devices are currently available. The procedure of endovascular repair has been evaluated in many institutions and the different devices are compared. The first results were encouraging, but complications like endoleak, dislocation or thrombosis of the graft occurred. By the available devices the stent application is only promising, if the known exclusion criteria are strictly respected. Therefore a careful preinterventional assessment of the patient by different imaging modalities is necessary. As the available results up to now are preliminary and the durability of the devices has to be controlled, multicenter studies are required to improve the devices and observe their long- term success in the exclusion of abdominal aortic aneurysms.


2012 ◽  
Vol 56 (6) ◽  
pp. 1826-1827
Author(s):  
Charles J. Keith ◽  
Marc A. Passman ◽  
Michael J. Gaffud ◽  
Zdenek Novak ◽  
Marjan U. Mujib ◽  
...  

2017 ◽  
Vol 65 (6) ◽  
pp. 151S-152S
Author(s):  
Karen Trang ◽  
Venita Chandra ◽  
Whitt Virgin-Dodwney ◽  
E. John. Harris ◽  
Jason T. Lee ◽  
...  

VASA ◽  
2018 ◽  
Vol 47 (3) ◽  
pp. 187-196 ◽  
Author(s):  
Aspasia Tzani ◽  
Ilias P. Doulamis ◽  
Ioannis Katsaros ◽  
Eirini Martinou ◽  
Dimitrios Schizas ◽  
...  

Abstract. Although endovascular repair of infrarenal abdominal aortic aneurysms (EVAR) presents a delicate alternative treatment for abdominal aortic aneurysms (AAA) with lower perioperative mortality, its long-term efficacy remains a matter of concern. The purpose of this study was to evaluate the currently reported mortality evidence after EVAR and to examine the possible effect of aneurysm status and the study period on mortality rates. The PubMed and Cochrane bibliographical databases were thoroughly searched for studies reporting on more than 1 000 patients with non-ruptured or ruptured infrarenal AAA, treated with EVAR from August 1991 to September 2016. A total of 10 910 titles/abstracts were retrieved and 121 studies were deemed relevant. Twenty-six studies met the inclusion criteria and reported on 354 500 patients with a mean age of 74.6 years. Almost all of the studies referred to elective EVAR and the mean aneurysm size was 5.58 cm. The most common early complication for elective EVAR was perioperative bleeding (1.9 %), whereas hospital-acquired pneumonia was a major concern in urgent EVAR (28.5 %). Conversion rate to open surgery was 1.2 %. The 30-day all-cause mortality rate was 4.84 % (1.7 % for non- ruptured aneurysms, 33.8 % for ruptured aneurysms).The overall all-cause late mortality in a mean follow-up period of 23.8 months was 19.1 %. The aneurysm-related late mortality rate was 3.4 %. With respect to the time period of patient enrollment, studies reporting on patients recruited before 2006 were found to face more secondary complications and higher late mortality rates than patients enrolled after 2005.The endovascular treatment of large and anatomically suitable infrarenal AAA in selected patients remains a safe alternative to open repair. Our findings demonstrate that newer studies show better long-term outcomes than the older ones, proposing a possible improvement of EVAR techniques and perioperative care and providing encouraging evidence for a wider application of EVAR.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sarah K. Garland ◽  
Michael O. Falster ◽  
C Barry Beiles ◽  
Anthony J. Freeman ◽  
Louisa R. Jorm ◽  
...  

2014 ◽  
Vol 60 (3) ◽  
pp. 830 ◽  
Author(s):  
Marc L. Schermerhorn ◽  
Dominique B. Buck ◽  
Thomas Curran ◽  
John C. McCallum ◽  
Alistair J. O'Malley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document